Ingevity Corporation (NYSE:NGVT – Get Free Report) has received an average rating of “Hold” from the five research firms that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $80.00.
Several equities analysts recently issued reports on NGVT shares. BMO Capital Markets reissued an “outperform” rating and set a $83.00 price target on shares of Ingevity in a report on Monday, March 2nd. Jefferies Financial Group reaffirmed a “buy” rating and set a $82.00 price objective on shares of Ingevity in a research note on Thursday, February 26th. Zacks Research upgraded shares of Ingevity to a “hold” rating in a research note on Tuesday, December 16th. Wall Street Zen downgraded Ingevity from a “strong-buy” rating to a “buy” rating in a report on Monday, March 9th. Finally, Wells Fargo & Company increased their price target on Ingevity from $65.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, February 27th.
View Our Latest Research Report on Ingevity
Institutional Trading of Ingevity
Ingevity Stock Performance
Ingevity stock opened at $63.54 on Monday. The firm has a market capitalization of $2.24 billion, a P/E ratio of -13.66 and a beta of 1.31. The stock has a fifty day moving average price of $68.95 and a two-hundred day moving average price of $60.23. Ingevity has a 52-week low of $28.49 and a 52-week high of $77.46. The company has a debt-to-equity ratio of 39.10, a current ratio of 1.33 and a quick ratio of 0.79.
Ingevity (NYSE:NGVT – Get Free Report) last issued its earnings results on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, missing the consensus estimate of $0.74 by ($0.16). Ingevity had a negative net margin of 13.51% and a positive return on equity of 126.25%. The firm had revenue of $255.10 million during the quarter, compared to analyst estimates of $257.27 million. During the same quarter in the prior year, the firm posted $0.95 EPS. The firm’s revenue for the quarter was down 3.2% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. As a group, analysts anticipate that Ingevity will post 4.45 EPS for the current fiscal year.
Ingevity Company Profile
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Featured Articles
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
